Bevacizumab Plus Vinorelbine in Treating Patients With Stage IV Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Male Breast Cancer|Recurrent Breast Cancer|Stage IV Breast Cancer
Interventions: BIOLOGICAL: bevacizumab|DRUG: vinorelbine tartrate|OTHER: laboratory biomarker analysis
Sponsor: National Cancer Institute (NCI)